Compare BHP Billiton Limited (BHP) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BHP Billiton Limited vs Nuwellis Inc — how do they compare? BHP Billiton Limited trades at $90.44 (market cap $227.94B), while Nuwellis Inc trades at $1.49 (market cap $522.76K). The key difference: BHP Billiton Limited is far larger — about 436031.8× Nuwellis Inc's market cap, and BHP Billiton Limited pays a 2.94% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| BHP | NUWE | |
|---|---|---|
Market Cap | $227.94B | $522.76K |
Sector | Basic Materials | Technology |
52-Week High | $93.15 | $220.50 |
52-Week Low | $52.14 | $1.42 |
Enterprise Value | $242.14B | -$1.29M |
Dividend Yield | 2.94% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BHP Billiton Limited
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
